For years, muscular dystrophy patients in the United States have been purchasing the drug deflazacort — used to stabilize muscle strength and keep patients mobile for a period of time — from companies in the United Kingdom at a manageable price of $1,600 a year.
Democracy Dies in Darkness
Opinion Why people should be able to buy drugs approved in other countries
February 14, 2017 at 11:16 a.m. EST